Dumanian v. Schwartz

CourtDistrict Court, N.D. Illinois
DecidedJuly 13, 2022
Docket1:19-cv-06771
StatusUnknown

This text of Dumanian v. Schwartz (Dumanian v. Schwartz) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Dumanian v. Schwartz, (N.D. Ill. 2022).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

GREGORY DUMANIAN, ) RANDA DUMANIAN, and ) ADOM DUMANIAN, ) ) Plaintiffs, ) ) No. 19 C 6771 v. ) ) Judge John Z. Lee MARK SCHWARTZ, YAJIA ) HU SCHWARTZ, LINDSEY ) SCHWARTZ, LEO SCHWARTZ, ) CAMILA LOZANO, TAX LIEN ) LAW GROUP, LLC, and ) SULION, LLC, ) ) Defendants. )

MEMORANDUM OPINION AND ORDER

Once friends and business partners, Dr. Gregory Dumanian and Dr. Mark Schwartz now stand on opposite sides of a bitter corporate governance dispute involving Mesh Suture, Inc. (“Mesh Suture”), a company they formed to develop and market a surgical suture of Dumanian’s invention. As Dumanian tells it, after Dumanian fired Schwartz as CEO of Mesh Suture, Schwartz expropriated nearly $4 million from the company account, blocked Dumanian and his family’s access to company email and work platforms, and published inflammatory accusations about Dumanian and his family to Mesh Suture investors and stakeholders. Schwartz then capitalized on Dumanian’s vulnerable position by coercing him to sign board minutes that gave Schwartz majority control of the company and a settlement agreement releasing all claims against Schwartz and his family in connection with the dispute. Dumanian, his wife Randa Dumanian, and their son Adom Dumanian (collectively “the Dumanians” or “Plaintiffs”) filed this lawsuit against Schwartz, his wife Yajia Hu Schwartz, his children, Lindsey and Leo Schwartz, Leo Schwartz’s

girlfriend Camila Lozano, and two business entities controlled by Schwartz (collectively “Defendants”). Plaintiffs seek rescission of the board minutes and the settlement agreement and a declaratory judgment that Dumanian validly terminated Schwartz as the CEO of Mesh Suture. Plaintiffs have moved for a preliminary injunction. For the reasons that follow, the Court grants Plaintiffs’ motion. I. Background The Court sets forth its factual findings below. These findings are based solely

on the evidence presented to the Court in connection with Plaintiffs’ motion and the Court’s assessment of the credibility of witnesses, who testified at the preliminary injunction hearing. Furthermore, in considering a motion for a preliminary injunction, the Court may consider evidence that may be inadmissible at trial, such as hearsay, to the extent that it finds that evidence reliable. Dexia Credit Loc. v. Rogan, 602 F.3d 879, 885 (7th Cir. 2010) (evidence that is inadmissible under the

Federal Rules of Evidence may be considered at a preliminary injunction hearing); S.E.C. v. Cherif, 933 F.2d 403, 412 n.8 (7th Cir. 1991) (“[H]earsay can be considered in entering a preliminary injunction.”). The Court has done so here. A. Formation and Early Years of Mesh Suture Dumanian has worked as a plastic surgeon at Northwestern Memorial Hospital in Chicago for over twenty-five years. Prelim. Inj. Hr’g Tr. at 7:6–8:15, Dumanian v. Schwartz, No. 19 C 6771 (N.D. Ill. Mar. 16, 2022) (“Hr’g Tr.”), ECF Nos. 209–211. Dumanian, who specializes in abdominal wall reconstruction and hernia repair, observed during his clinical practice that the sutures he used to repair surgical

incisions frequently cut through tissues and created complications. Id. at 10:8–12. One day in 2008, Dumanian “flashed [an] idea” for how to solve that problem—a suture made of mesh that allows tissue to grow into the suture itself, making it more resistant to tearing and able to achieve a better hold. Id. at 11:8; see id. at 11:4–11, 12:3–8. To commercially develop the “mesh suture” idea, Dumanian obtained a patent and formed a company to license the patent rights from Northwestern Hospital.1 See

id. at 11:15–17, 13:17–19. To help run the business, Dumanian contacted Schwartz, who had become his friend after Dumanian had performed Schwartz’s abdominal wall surgery years earlier. See id. at 263:3–264:7. Schwartz agreed to help with the business, and in 2012 the men formed Advanced Suture Inc., a Delaware corporation, to hold the license and develop the invention. Id. at 18:1–3, 270:1–9. In October 2015, they signed a Founders

Agreement reincorporating Advanced Suture in Puerto Rico and, at the same time, forming Mesh Suture Inc., another Puerto Rico corporation. Id. at 18:9–14; see generally Pls.’ Ex. 27, Am. Reinstated Founders’ Agreement (Oct. 15, 2015) (“Founders’ Agreement”).

1 Because Dumanian had developed the mesh suture concept while working at Northwestern Hospital, it owned the patent rights. Hr’g Tr. at 11:15–17, 13:17–19. The Founders’ Agreement gave Dumanian and Schwartz each a roughly fifty percent stake in Mesh Suture, with each partner holding 250 shares of preferred stock, which they purchased at $1,000 per share. Founders’ Agreement at 2.

Dumanian insisted, however, that he have ultimate control of the company, so the agreement provided Dumanian with one $10 share of common stock, which would give him the “final say” over Schwartz. Hr’g Tr. at 19:7–17; Founders’ Agreement at 2. The Founders’ Agreement also provided for a board of directors consisting of: up to three (3) persons designated by Dr. Dumanian, for so long as Dr. Dumanian continues to hold Shares or Common Stock of the Company, one of whom shall initially be Dr. Dumanian . . .

up to [t]wo (2) persons designated by Dr. Schwartz, for so long as Dr. Schwartz continues to hold Shares or Common Stock of the Company, one of whom shall initially be Dr. Schwartz . . .

one (1) person designated by the CEO;

one (1) person who shall be designated by a majority of the holders of the Series A Preferred on or after the initial close of a Series A Preferred financing by the Company; and

two (2) persons who shall be designated by a majority of the Board. Id. Because Dumanian and Schwartz appointed Schwartz as the CEO, they each controlled three board seats at the time of incorporation, with three board seats to be filled later, after the initial (“Series A”) round of outside investment. Id.; see Hr’g Tr. at 21:10–20. Schwartz also signed an employment agreement with the company. The agreement gave Dumanian a personal right to terminate Schwartz as CEO “with or without cause on 90 days’ written notice . . . at any time.” Pls.’ Ex. 7, Schwartz

Employment Agreement ¶ 6(a); see Hr’g Tr. at 21:21–24. If Dumanian chose to exercise that right and appoint his own CEO, he would have control of four board seats to Schwartz’s two. Hr’g Tr. at 21:21–24. About two years after the founding of the company, Mesh Suture started to raise Series A funds. The first round of investments, which took place in late 2017 and early 2018, raised about $4 million from a wide array of investors, including Dumanian’s family, the Armenian community in Chicago, Dumanian’s colleagues at

Northwestern, and plastic surgeons who had become familiar with the mesh suture concept from Dumanian’s lectures and publications. Id. at 26:18–27:17. A second round of Series A funding took place in late 2018 and early 2019, and raised about $6 million from the same group of investors. Id. at 28:15–20. Dumanian and Schwartz each invested an additional $324,000 during the Series A round, on top of their initial $250,000 investments. Id. at 29:7–19.

B. Schwartz’s Termination and Its Immediate Aftermath By mid-2019, Dumanian and Schwartz started to clash. One source of conflict was Schwartz’s numerous requests to take out a $324,000 loan from the company to help with his personal financial troubles. See id. at 32:2–36:3. Things came to a head during the week of August 19, 2019.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Dexia Credit Local v. Rogan
602 F.3d 879 (Seventh Circuit, 2010)
Califano v. Yamasaki
442 U.S. 682 (Supreme Court, 1979)
Nken v. Holder
556 U.S. 418 (Supreme Court, 2009)
Bank of New York v. First Millennium, Inc.
607 F.3d 905 (Second Circuit, 2010)
Bonte v. U.S. Bank, N.A.
624 F.3d 461 (Seventh Circuit, 2010)
Roland MacHinery Company v. Dresser Industries, Inc.
749 F.2d 380 (Seventh Circuit, 1984)
In Re: Aimster Copyright Litigation
334 F.3d 643 (Seventh Circuit, 2003)
Clyde Ammons v. Aramark Uniform Services, Inc.
368 F.3d 809 (Seventh Circuit, 2004)
Mazurek v. Armstrong
520 U.S. 968 (Supreme Court, 1997)
Russian Media Group, LLC v. Cable America, Inc.
598 F.3d 302 (Seventh Circuit, 2010)
Greenfield v. Philles Records, Inc.
780 N.E.2d 166 (New York Court of Appeals, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
Dumanian v. Schwartz, Counsel Stack Legal Research, https://law.counselstack.com/opinion/dumanian-v-schwartz-ilnd-2022.